A nurse practitioner must be able to quickly and effectively address the patient’s problems and concerns and propose the best possible outcome to resolve the patient’s issue. The Clinical Practice Guide will help respond to the patient’s concerns. In this case, a quick decision and the selection of the right way to improve clinical performance without harm to health are required. The guide emphasizes patient safety as paramount, so it is planned to address the client’s concerns by emphasizing the explanation of the safe approach.
The recommendation evaluation process definitely promotes quick decisions in clinical practice. When a patient, as in the case of Amanda, requires a quick solution to the existing problem, it is necessary to effectively evaluate all options in the shortest possible time. In Amanda’s case, it quickly becomes clear that Belviq is not the right fit for her. The main active ingredient, lorcaserin, has not been approved by the European Medical Agency due to concerns about psychiatric problems such as worsening depression, suicidal ideation, and psychosis (Tak & Lee, 2021). The patient is already too worried about her weight problems, it is necessary not to make them worse. A quick assessment in this case will help to avoid negative processes for the patient.
The rapid assessment process is very useful for the clinical practice of a nurse using an evidence-based approach. It helps quickly and efficiently eliminate inappropriate options and find ways that have proven effectiveness. For example, Amanda should be advised to follow a diet, physical activity, which has been proven to reduce weight by at least 5% and will reduce blood sugar levels in type 2 diabetes (American Diabetes Association, 2016). Amanda’s condition requires a comprehensive approach, as diabetes is associated with obesity, forming part of the metabolic syndrome, which is associated with a high likelihood of developing cardiovascular disease (Saklayen, 2018). Therefore, Amanda needs a comprehensive approach to change her lifestyle to a healthier one to reduce risks. It is noteworthy that this information for selecting recommendations can be found very quickly, which is important for the immediate start of treatment.
References
American Diabetes Association. (2016). Obesity management for the treatment of type 2 diabetes. Diabetes Care, 39(10). 547-551. Web.
Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Current hypertension reports, 20(2), 1-8. Web.
Tak, Y. J., & Lee, S. Y. (2021). Anti-obesity drugs: long-term efficacy and safety: an updated review. The World Journal of Men’s Health, 39(2), 208. Web.